Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.4-Antibody has entered into a partnership agreement with Human Genome Sciences (HGS) to discover and develop human therapeutic antibodies.
Subscribe to our email newsletter
The collaboration allows HGS to develop 4-Antibody’s proprietary in vitro Retrocyte Display technology (Retroviral B lymphocyte Display) to discover sources for antibody drug candidates.
Retrocyte Display creates therapeutic antibody drug candidates using a flow cytometry by integrating full-length IgG format human antibody libraries expressed in mammalian B cells.
4-Antibody CEO Robert Burns said they are delighted to announce their second collaboration with a pharmaceutical partner.